ArticleBMJ open2022

Efficacy and safety of edoxaban in patients with chronic thromboembolic pulmonary hypertension: protocol for a multicentre, randomised, warfarin-controlled, parallel group trial - KABUKI trial.

Kazuya Hosokawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.